热门资讯> 正文

BioCardia GAAP每股收益为-0.40美元

2025-08-12 01:58

BioCardia press release (NASDAQ:BCDA): Q2 GAAP EPS of -$0.40.
Net cash used in operations for the three months ended June 2025 was approximately $1.6 million, as compared to approximately $1.3 million for the three months ended June 2024. Net cash used in operations for the six months ended June 2025 was approximately $3.3 million, as compared to approximately $2.8 million for the six months ended June 2024.

More on BioCardia

BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript
Seeking Alpha’s Quant Rating on BioCardia
Historical earnings data for BioCardia
Financial information for BioCardia

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。